WHO ICTRP trial
Double blind, randomized, placebo-controlled, two-way crossover, pilot study to…
EUCTR2008-006837-28-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-006837-28-BE |
|---|---|
| Public title | Double blind, randomized, placebo-controlled, two-way crossover, pilot study to assess the effect of high dose N-acetylcysteine on small airways and on inflammation and oxidative stress in COPD patients |
| Scientific title | Double blind, randomized, placebo-controlled, two-way crossover, pilot study to assess the effect of high dose N-acetylcysteine on small airways and on inflammation and oxidative stress in COPD patients |
| Primary sponsor | University Hospital Antwerp; Department Respiratory Medicine |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Therapeutic exploratory (Phase II): Therapeutic confirmatory - (Phase III): Therapeutic use (Phase IV): yes |
| Countries | Belgium |
| Conditions | Chronic Obstructive Pulmonary Disease |
| Interventions | Trade Name: Lysomucil 600mg effervescent tablets Pharmaceutical Form: Effervescent tablet Pharmaceutical form of the placebo: Effervescent tablet Route of administration of the placebo: Oral use |
| Registration date | Nov 14, 2008 |
| Secondary IDs | PML_DOC_0804 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: